Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00880087 · ClinicalTrials.gov registry record · NA
Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 329
- Enrollment target
NCT00880087 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 329 participants.
The verdict
NCT00880087, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 329 participants
- Enrollment target
Study Summary
Cardiac arrest is a sudden, unexpected loss of heart function. Therapeutic hypothermia, in which the body's temperature is lowered and maintained several degrees below normal for a period of time, has been used to successfully treat adults who have experienced cardiac arrest. This study will evaluate the efficacy of therapeutic hypothermia at increasing survival rates and reducing the risk of brain injury in infants and children who experience a cardiac arrest while in the hospital.
Interventions
- PROCEDURE Therapeutic Hypothermia
- PROCEDURE Therapeutic Normothermia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 329 participants |
| Start Date | 2009-09 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00880087
The ClinicalTrials.gov registry entry for NCT00880087 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 329 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Therapeutic Hypothermia is the first listed.
NCT00880087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00880087 about?
NCT00880087 is a clinical study titled "Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial". Cardiac arrest is a sudden, unexpected loss of heart function. Therapeutic hypothermia, in which the body's temperature is lowered and maintained several degrees below normal for a period of time, has been used to successfully treat adults who have experienced cardiac arrest. This study will evaluat...
What is the current status of trial NCT00880087?
This trial is currently completed. It is a NA study. The enrollment target is 329 participants. The study started on 2009-09. Estimated completion is 2016-02.
What interventions are being tested in trial NCT00880087?
The interventions under investigation include: Therapeutic Hypothermia (PROCEDURE), Therapeutic Normothermia (PROCEDURE).
Who is sponsoring clinical trial NCT00880087?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.